Latest Scripps Translational Science Institute Stories
SAN DIEGO, Oct. 3, 2012 /PRNewswire/ -- Scripps Health announced today that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute, which was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine. The funding will advance clinical trials of cutting-edge wireless biosensor systems,...
A new blood test developed to predict heart attacks as much as two weeks in advance could be a savior to more than 2.5 million Americans at risk, medical news site MyHealthNewsDaily reports. The test, which measures circulating endothelial cells (CECs) in the blood, was used in a study of 50 patients led by Scripps Translational Science Institute (STSI) – a collaborative program between Scripps Health and the Scripps Research Institute (SRI). CECs in heart attack patients are larger...
SAN DIEGO, March 21, 2012 /PRNewswire/ -- New findings from a landmark research study led by Scripps Translational Science Institute (STSI) - a collaborative program between Scripps Health and The Scripps Research Institute (TSRI) - shows a promising new blood test may be useful in helping doctors predict who is at risk for an imminent heart attack. (Photo: http://photos.prnewswire.com/prnh/20120321/LA74303) Results of the study titled, "Characterization of Circulating...
SAN DIEGO, Jan. 17, 2012 /PRNewswire/ -- New findings from a research study led by physicians at Scripps Health reveal that the investigational drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications. Initial results from the BRIDGE trial will be published Jan....
A substantial number of people with eating disorders, such as anorexia nervosa have a chronic course. They are severely underweight and have a high likelihood of dying from malnutrition. No treatment has been found that helps people who are chronically ill. Now, a new study sheds light on the reason that some people have poor outcome.An international team of scientists, led by researchers at the University of California, San Diego (UCSD) School of Medicine and the Scripps Translational...
SAN DIEGO, July 4, 2011 /PRNewswire/ -- Nearly 200 years after the introduction of the stethoscope, the accuracy of a pocket ultrasound device that enables a physician to "look" at a patient's heart during routine physical exams has been validated for the first time in peer-reviewed research led by Scripps Translational Science Institute (STSI) and Scripps Health. To view the multimedia assets associated with this release, please click:...
SAN DIEGO, Feb. 10, 2011 /PRNewswire/ -- A new study involving researchers at the Scripps Translational Science Institute (STSI) and Scripps Health patients reveals major scientific progress in understanding the mechanism of heart disease at the molecular and genomic levels. STSI is an initiative of Scripps Health in collaboration with The Scripps Research Institute. The study findings establish a link between coronary artery disease (CAD) and genetic susceptibility resulting in an abnormal...
New research shows that people who participate in direct to consumer DNA testing aren't likely to panic over the results, but are likely to undergo corresponding medical exams in the event that the results claim they are at risk for certain diseases.Those findings are the result of the Scripps Genomic Health Initiative (SGHI), a Scripps Health / Scripps Translational Science Institute (STSI) study that polled more than 2,000 personal genetic test users and found "no evidence that the...
LAS VEGAS, Jan. 8 /PRNewswire-USNewswire/ -- Dr. Eric J. Topol, chief academic officer of Scripps Health and chief medical officer of the West Wireless Health Institute (WWHI), will join Qualcomm chairman and CEO Dr. Paul E. Jacobs during Jacobs' keynote at International CES on Friday, January 8, 2010, to highlight a variety of digital medical devices that offer physicians and consumers the ability to remotely monitor fitness, sleep, vital signs and pre-natal activity. WWHI is one of the...
RainDance Technologies, a provider of droplet-based solutions for human health and disease research, has announced a collaboration with the Scripps Translational Science Institute to utilize RainDance's new RainStorm technology as a solution to a key bottleneck in large-scale targeted sequencing studies. Scripps Translational Science Institute's (STSI) genomic researchers are now looking to America's healthy elderly, known as the wellderly - those 80 years and older with no history of...
